Literature DB >> 15985222

Immunization with glutathione S-transferase and mutant toxic shock syndrome toxin 1 fusion protein protects against Staphylococcus aureus infection.

Jing-Chun Cui1, Dong-Liang Hu, Yan-Chun Lin, Ai-Dong Qian, Akio Nakane.   

Abstract

To investigate whether immunization with glutathione S-transferase (GST) and mutant toxic shock syndrome toxin 1 (mTSST-1) fusion protein can protect against Staphylococcus aureus infection, we purified a non-toxic mutant GST-mTSST-1 fusion protein. Mice were immunized with the GST-mTSST-1 plus alum adjuvant and then challenged with viable S. aureus. The results showed that the survival rate of GST-mTSST-1-immunized group was higher and the bacteria counts in the organs were significantly lower than those of the non-immunized mice. Immunization with GST-mTSST-1 induced strongly the production of TSST-1 specific antibodies, especially immunoglobulin G1 and immunoglobulin G2b. Furthermore, the serum samples from GST-mTSST-1-immunized mice also significantly inhibited interferon-gamma and tumor necrosis factor-alpha production from murine spleen cells by TSST-1. These results suggest that vaccination with GST-mTSST-1 provides protection against S. aureus infection and that the protection might be mediated by TSST-1-neutralizing antibody.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15985222     DOI: 10.1016/j.femsim.2005.01.010

Source DB:  PubMed          Journal:  FEMS Immunol Med Microbiol        ISSN: 0928-8244


  6 in total

Review 1.  Antistaphylococcal vaccines and immunoglobulins: current status and future prospects.

Authors:  Stan Deresinski
Journal:  Drugs       Date:  2006       Impact factor: 9.546

Review 2.  Progress in the development of effective vaccines to prevent selected gram-positive bacterial infections.

Authors:  Michael S Bronze; James B Dale
Journal:  Am J Med Sci       Date:  2010-09       Impact factor: 2.378

3.  Serologic assay to quantify human immunoglobulin G antibodies to the Staphylococcus aureus iron surface determinant B antigen.

Authors:  Michael D Raedler; Samantha Heyne; Erica Wagner; Sheri K Shalkowski; Susan Secore; Annaliesa S Anderson; James Cook; Leslie Cope; Tessie McNeely; Mary Retzlaff; Jon Shanter; Leonard J Rubinstein; Tina Green; N Kartsonis; Mark T Esser
Journal:  Clin Vaccine Immunol       Date:  2009-03-25

4.  Protective effect of recombinant staphylococcal enterotoxin A entrapped in polylactic-co-glycolic acid microspheres against Staphylococcus aureus infection.

Authors:  Liben Chen; Shuang Li; Zhengfang Wang; Ruilong Chang; Jingliang Su; Bo Han
Journal:  Vet Res       Date:  2012-03-19       Impact factor: 3.683

5.  Toxic Shock Syndrome Toxin 1 Induces Immune Response via the Activation of NLRP3 Inflammasome.

Authors:  Lianci Peng; Jiali Jiang; Tingting Chen; Dongyi Xu; Fengqing Hou; Qingyuan Huang; Yuanyi Peng; Chao Ye; Dong-Liang Hu; Rendong Fang
Journal:  Toxins (Basel)       Date:  2021-01-18       Impact factor: 4.546

6.  Structural and functional properties of antibodies to the superantigen TSST-1 and their relationship to menstrual toxic shock syndrome.

Authors:  Rita Kansal; Catherine Davis; Melanie Hansmann; Jon Seymour; Jeffrey Parsonnet; Paul Modern; Steve Gilbert; Malak Kotb
Journal:  J Clin Immunol       Date:  2007-03-06       Impact factor: 8.542

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.